TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mentalization-Based Treatment in Groups for Adolescents With Borderline Personality Disorder (BPD) or Subthreshold BPD Versus Treatment As Usual - the M-GAB Randomized Controlled Trial
Brief Summary: Background: Although it is now possible to diagnose Borderline Personality Disorder (BPD) in adolescents younger than 18 years according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), and studies indicates that BPD can be reliably diagnosed in adolescence, only a few evidence based treatment programmes for adolescent BPD exists. Mentalization-based treatment (MBT), including group psychotherapy, has repeatedly shown to be effective in treating adult BPD, but in the case of adolescents, only individual MBT have been tested and found to be effective.

Aims/hypotheses: We will test whether group based MBT (MBT-G), including an introductory programme for patients (MBT-I) and their parents (MBT-P) is more effective than Treatment As Usual (TAU) in treating adolescents with BPD or subthreshold BPD.

Methods/Design: 112 patients referred to child and adolescent psychiatric clinics in Region Zealand will be randomized to either MBT or TAU. Inclusion criteria: Meeting DSM-V BPD-criteria at the threshold (five criteria) or sub threshold level (4 criteria). Follow-up will be at three and 12 months.

Discussion: Early intervention is especially important in relation to personality psychopathology and has long-term benefits for patients, their families and society. In addition to being cost effective, using the group modality in the treatment of BPD may have several advantages. This is the first Randomized Controlled Trial (RCT) to test the effectiveness of MBT in groups for adolescents.


Options:
A: Arm Label: Relaxation group; Type: ACTIVE_COMPARATOR; Interventions: Other: Relaxation group | Arm Label: Psychoeducational group; Type: EXPERIMENTAL; Interventions: Behavioral: Interventional group : PEPSUI psychoeducational program | Intervention Type: BEHAVIORAL; Name: Interventional group : PEPSUI psychoeducational program; Assigned to Arm(s): Psychoeducational group | Intervention Type: OTHER; Name: Relaxation group; Assigned to Arm(s): Relaxation group
B: Intervention Type: BEHAVIORAL; Name: Problem-Solving Skills Training; Assigned to Arm(s): N/A
C: Arm Label: Mentalization Based Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Mentalization Based Treatment | Arm Label: Treatment As Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Mentalization Based Treatment; Assigned to Arm(s): Mentalization Based Treatment | Intervention Type: BEHAVIORAL; Name: Treatment As Usual; Assigned to Arm(s): Treatment As Usual
D: Arm Label: Mindfulness-based self-care; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based self care | Arm Label: Life as usual control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based self care; Assigned to Arm(s): Mindfulness-based self-care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder
Brief Summary: The goal of this study is to look at how a type of drug called cannabinoids are related to the processing of fear signals, the experience of emotions and fear, and the pattern of activity in the brain that is involved in these processes and how this relates to the development of post-traumatic stress disorder (PTSD). PTSD is an anxiety disorder that occurs after experiencing a traumatic event(s) and is characterized by unwanted memories of the trauma(s) through flashbacks or nightmares, avoidance of situations that remind the person of the event, difficulty experiencing emotions, loss of interest in activities the person used to enjoy, and increased arousal, such as difficulty falling asleep or staying asleep, anger and hypervigilance. The information gained from this study could lead to the development of new treatments for persons who suffer from anxiety or fear-based disorders.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: HCORT; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocortisone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): HCORT
B: Arm Label: Treatment - prazosin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prazosin | Arm Label: Control - placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Intervention Type: DRUG; Name: Prazosin; Assigned to Arm(s): Treatment - prazosin | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Control - placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Dronabinol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dronabinol | Intervention Type: DRUG; Name: Dronabinol; Assigned to Arm(s): Dronabinol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Control Arm - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Arm - Propranolol hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: Propranolol Hydrochloride | Intervention Type: DRUG; Name: Propranolol Hydrochloride; Assigned to Arm(s): Intervention Arm - Propranolol hydrochloride

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multifaceted Depression and Cardiovascular Program for Low-Income Patients
Brief Summary: 1. Implement an evidence-based structured care approach that includes screening; acute treatment and relapse prevention follow-up tailored for public sector clinics and low-income and minority patients.
2. Adapt an evidence-based collaborative care model for primary care, implement the adapted model, evaluate and further refine the model based on the pilot experience, and produce and disseminate a detailed manual for use in public sector clinics.
3. Evaluate Multifaceted Depression and Cardiovascular Program (MDCP) in an open trial to determine: its acceptance by patients, medical providers, and organizational decision-makers; patient depression treatment adherence; its direct cost; and the size and variability of change from baseline in the primary outcome measures: depressive symptoms, functional status, quality of life, health service use, and cardiac status at 6 and 12 month follow-up.


Options:
A: Arm Label: Assistance with Pain Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Assistance with Pain treatment | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistance with Pain treatment; Assigned to Arm(s): Assistance with Pain Treatment
B: Arm Label: Collaborative depression care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): Collaborative depression care
C: Arm Label: Stepped Care; Type: EXPERIMENTAL; Interventions: Drug: Stepped care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Stepped care; Assigned to Arm(s): Stepped Care
D: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multifaceted Depression and Cardiovascular Program for Low-Income Patients
Brief Summary: 1. Implement an evidence-based structured care approach that includes screening; acute treatment and relapse prevention follow-up tailored for public sector clinics and low-income and minority patients.
2. Adapt an evidence-based collaborative care model for primary care, implement the adapted model, evaluate and further refine the model based on the pilot experience, and produce and disseminate a detailed manual for use in public sector clinics.
3. Evaluate Multifaceted Depression and Cardiovascular Program (MDCP) in an open trial to determine: its acceptance by patients, medical providers, and organizational decision-makers; patient depression treatment adherence; its direct cost; and the size and variability of change from baseline in the primary outcome measures: depressive symptoms, functional status, quality of life, health service use, and cardiac status at 6 and 12 month follow-up.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): 2
B: Arm Label: TEAMcare treatment of diabetes; Type: ACTIVE_COMPARATOR; Interventions: Other: TEAMcare treatment of diabetes | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: TEAMcare treatment of diabetes; Assigned to Arm(s): TEAMcare treatment of diabetes
C: Arm Label: Collaborative depression care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): Collaborative depression care
D: Arm Label: REP + EF; Type: EXPERIMENTAL; Interventions: Behavioral: External Facilitation | Arm Label: REP + EF/IF; Type: EXPERIMENTAL; Interventions: Behavioral: External + Internal Facilitation | Intervention Type: BEHAVIORAL; Name: External Facilitation; Assigned to Arm(s): REP + EF | Intervention Type: BEHAVIORAL; Name: External + Internal Facilitation; Assigned to Arm(s): REP + EF/IF

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Combined Ergonomic Health Promotion Intervention on Employee Health
Brief Summary: Our objective in this pilot study is to test the combined effect of a) replacing office workers' sedentary workstations with active workstations (LifeBalance Station) and b) optimizing computer workstation ergonomics on daily occupational sedentary time, cardiometabolic risk factors, musculoskeletal symptom health outcomes and work productivity.


Options:
A: Arm Label: Reduction in sitting time; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Arm Label: Increase in sit-to-stand transitions; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Intervention Type: BEHAVIORAL; Name: Sedentary behavior; Assigned to Arm(s): Increase in sit-to-stand transitions, Reduction in sitting time
B: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group
C: Arm Label: tailored group; Type: EXPERIMENTAL; Interventions: Behavioral: Start to stand | Arm Label: generic group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: generic advice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Start to stand; Assigned to Arm(s): tailored group | Intervention Type: BEHAVIORAL; Name: generic advice; Assigned to Arm(s): generic group
D: Arm Label: Move; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Move | Arm Label: Stand & Move; Type: EXPERIMENTAL; Interventions: Device: Sit-Stand workstation, Behavioral: Move | Intervention Type: DEVICE; Name: Sit-Stand workstation; Assigned to Arm(s): Stand & Move | Intervention Type: BEHAVIORAL; Name: Move; Assigned to Arm(s): Move, Stand & Move

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Combined Ergonomic Health Promotion Intervention on Employee Health
Brief Summary: Our objective in this pilot study is to test the combined effect of a) replacing office workers' sedentary workstations with active workstations (LifeBalance Station) and b) optimizing computer workstation ergonomics on daily occupational sedentary time, cardiometabolic risk factors, musculoskeletal symptom health outcomes and work productivity.


Options:
A: Arm Label: High intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Low intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): High intensity intervention group, Low intensity intervention group
B: Arm Label: Treadmill workstation; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill workstation, Behavioral: Health talk | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Behavioral: Health talk | Intervention Type: BEHAVIORAL; Name: Treadmill workstation; Assigned to Arm(s): Treadmill workstation | Intervention Type: BEHAVIORAL; Name: Health talk; Assigned to Arm(s): Control group, Treadmill workstation
C: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk
D: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Combined Ergonomic Health Promotion Intervention on Employee Health
Brief Summary: Our objective in this pilot study is to test the combined effect of a) replacing office workers' sedentary workstations with active workstations (LifeBalance Station) and b) optimizing computer workstation ergonomics on daily occupational sedentary time, cardiometabolic risk factors, musculoskeletal symptom health outcomes and work productivity.


Options:
A: Arm Label: tailored group; Type: EXPERIMENTAL; Interventions: Behavioral: Start to stand | Arm Label: generic group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: generic advice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Start to stand; Assigned to Arm(s): tailored group | Intervention Type: BEHAVIORAL; Name: generic advice; Assigned to Arm(s): generic group
B: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
C: Arm Label: Sitting time Change Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Sitting time Change Intervention | Arm Label: Active Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Sitting time Change Intervention; Assigned to Arm(s): Sitting time Change Intervention
D: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Combined Ergonomic Health Promotion Intervention on Employee Health
Brief Summary: Our objective in this pilot study is to test the combined effect of a) replacing office workers' sedentary workstations with active workstations (LifeBalance Station) and b) optimizing computer workstation ergonomics on daily occupational sedentary time, cardiometabolic risk factors, musculoskeletal symptom health outcomes and work productivity.


Options:
A: Arm Label: Treadmill workstation; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill workstation, Behavioral: Health talk | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Behavioral: Health talk | Intervention Type: BEHAVIORAL; Name: Treadmill workstation; Assigned to Arm(s): Treadmill workstation | Intervention Type: BEHAVIORAL; Name: Health talk; Assigned to Arm(s): Control group, Treadmill workstation
B: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group
C: Arm Label: Biopsychosocial; Type: EXPERIMENTAL; Interventions: Behavioral: Biopsychosocial | Arm Label: Reference; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reference | Intervention Type: BEHAVIORAL; Name: Biopsychosocial; Assigned to Arm(s): Biopsychosocial | Intervention Type: BEHAVIORAL; Name: Reference; Assigned to Arm(s): Reference
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: educational program, Other: exercise program, Other: Self-led exercises | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: educational program; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: exercise program; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Self-led exercises; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIIB, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients With Mild Stroke: Rapidly Improving Symptoms and Minor Neurologic Deficits (PRISMS)
Brief Summary: PRISMS is a double-blind, multicenter, randomized, Phase IIIb study to evaluate the efficacy and safety of intravenous (IV) alteplase in participants with mild acute ischemic strokes that do not appear to be clearly disabling. Participants will be randomized in a 1:1 ratio to receive within 3 hours of last known well time either 1) one dose of IV alteplase and one dose of oral aspirin placebo or 2) one dose of IV alteplase placebo and one dose of oral aspirin 325 milligrams (mg).


Options:
A: Arm Label: Alteplase Placebo + Aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Alteplase Placebo, Drug: Aspirin | Arm Label: Alteplase + Aspirin Placebo; Type: EXPERIMENTAL; Interventions: Drug: Alteplase, Drug: Aspirin Placebo | Intervention Type: DRUG; Name: Alteplase; Assigned to Arm(s): Alteplase + Aspirin Placebo | Intervention Type: DRUG; Name: Alteplase Placebo; Assigned to Arm(s): Alteplase Placebo + Aspirin | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Alteplase Placebo + Aspirin | Intervention Type: DRUG; Name: Aspirin Placebo; Assigned to Arm(s): Alteplase + Aspirin Placebo
B: Arm Label: TICAGRELOR; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor | Arm Label: TICAGRELOR PLACEBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ticagrelor; Assigned to Arm(s): TICAGRELOR | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): TICAGRELOR PLACEBO
C: Arm Label: 1 mg PF-03049423; Type: EXPERIMENTAL; Interventions: Drug: PF-03049423 | Arm Label: 3 mg of PF-03049423; Type: EXPERIMENTAL; Interventions: Drug: PF-03049423 | Arm Label: 6 mg of PF-03049423; Type: EXPERIMENTAL; Interventions: Drug: PF-03049423 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: PF-03049423; Assigned to Arm(s): 1 mg PF-03049423 | Intervention Type: DRUG; Name: PF-03049423; Assigned to Arm(s): 3 mg of PF-03049423 | Intervention Type: DRUG; Name: PF-03049423; Assigned to Arm(s): 6 mg of PF-03049423 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Aggrenox bid (ASA 25mg/Dipyridamole ER 200mg); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: ASA 100 mg qd; Assigned to Arm(s): N/A

Answer: A